Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Miriam Elizabeth Morris has worked on the following 9 EPO patent applications which have been published in the last five years:

EP12807562

IBUPROFEN CHEWABLE TABLET

IPC classification:
A61K 9/20, A61K 31/192, A61P 29/00
Agent:
Miriam Elizabeth Morris, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12782731

SUSTAINED RELEASE PARACETAMOL FORMULATIONS

IPC classification:
A61K 9/20, A61K 9/22, A61K 9/24, A61K 31/167, A61P 9/02
Applicant:
GlaxoSmithKline LLC
Agent:
Miriam Elizabeth Morris, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14766225

NOVEL SOLUBLE GUANYLATE CYCLASE ACTIVATORS AND THEIR USE

IPC classification:
A61K 31/4439, A61K 31/444, A61P 27/00, C07D 401/04, C07D 401/14
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Miriam Elizabeth Morris, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14771907

DENTIFRICE COMPOSITION COMPRISING SINTERED HYDROXYAPATITE

IPC classification:
A61K 8/24, A61Q 11/00
Applicant:
Glaxo Group Limited
Agent:
Miriam Elizabeth Morris, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP14815332

DENTIFRICE COMPOSITION COMPRISING SPHERICAL FUSED ALUMINIUM OXIDE PARTICLES

IPC classification:
A61K 8/02, A61K 8/26, A61Q 11/00
Applicant:
Glaxo Group Limited
Agent:
Miriam Elizabeth Morris, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15726738

PREPARATION AND USE OF CRYSTALLINE BETA-D-NICOTINAMIDE RIBOSIDE

IPC classification:
A61K 31/706, A61P 3/00, A61P 21/00, A61P 31/10, A61P 43/00, C07H 1/00, C07H 19/048
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Miriam Elizabeth Morris, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15729244

NICOTINAMIDE RIBOSIDE ANALOGS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 31/7064, A61P 3/10, A61P 17/00, A61Q 17/00, C07H 19/048
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Miriam Elizabeth Morris, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15842532

NOVEL FORMULATIONS

IPC classification:
A61K 31/74
Agent:
Miriam Elizabeth Morris, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature